Course and treatment of buprenorphine/naloxone withdrawal: An analysis of case reports

Joseph Westermeyer, Elinore F. McCance-Katz

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Currently published information on buprenorphinenaloxone withdrawal recommends a gradually decreasing dosage over weeks to months. In this case report, abrupt cessation of buprenorphine/naloxone at various doses, and after variable durations of treatment, resulted in mild opiate withdrawal lasting over approximately 1-2 days that did not require additional opioid medication or only specific symptom-relieving, non-opioid, medications. Lengthy withdrawal regimens might prolong withdrawal symptoms unnecessarily, perhaps increasing the risk of re-addiction. Controlled studies of buprenorphine/naloxone withdrawal regimens over varying time frames would help to illuminate the most effective means of opioid discontinuation and inform clinical care.

Original languageEnglish (US)
Pages (from-to)401-403
Number of pages3
JournalAmerican Journal on Addictions
Volume21
Issue number5
DOIs
StatePublished - Sep 2012

Fingerprint

Dive into the research topics of 'Course and treatment of buprenorphine/naloxone withdrawal: An analysis of case reports'. Together they form a unique fingerprint.

Cite this